Crossmark

Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis

Crossref DOI link: https://doi.org/10.1186/s40478-019-0692-8

Published Online: 2019-03-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rimelen, V. http://orcid.org/0000-0002-9231-1978
Ahle, G.

Pencreach, E.

Zinniger, N.

Debliquis, A.

Zalmaï, L.

Harzallah, I.

Hurstel, R.

Alamome, I.

Lamy, F.

Voirin, J.

Drénou, B.
Funding

Funding for this research was provided by:

Ligue Contre le Cancer
License Information

Text and Data Mining valid from 2019-03-18
More Information

Article History

Received: 22 January 2019

Accepted: 28 February 2019

First Online: 18 March 2019

Ethics approval and consent to participate

: All patients had given written informed consent. An institutional review board had approved the study, which was conducted in accordance with the declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.